Dosidal · Switzerland

Rapibloc, Pulver zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68611 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68611
atc: C07AB14
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2022-10-19
term: zugelassen
valid_until: 2027-10-18
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: C07AB14
authorisation_number: 68611
form: PULVI
holder: OrPha Swiss GmbH
holder_partner_nr: 1001693
it_number: 02.03.0.
name: Rapibloc, Pulver zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
UvKY_qST5H3yNnvoSmeXNdpCr1ooQA6QuQEO_CKZRJls8-CUXo9Aof6mXcAqYV6NrcwnQqRlcYPLELVoGcnAyg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal